DARTMOUTH, Nova Scotia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and Chief Financial Officer Pierre Labbé will present a corporate update at two upcoming investor conferences.

BIO Investor Forum, San Francisco, CA

• Date: Thursday, October 18, 2018
• Time: 9:00 a.m. PT
• Location: The Elizabeth Room, Westin St. Francis
• A live webcast of the presentation will be accessible via the following URL: http://www.veracast.com/webcasts/bio/investorforum2018/15132412139.cfm.   

Dawson James Small Cap Growth Conference, Jupiter, FL

• Date: Tuesday, October 30, 2018
• Time: 10:30 a.m. ET
• Location: Track 2 - Preserve Ballroom B, Wyndham Grand Jupiter Hotel
• A live webcast of the presentation will be accessible via the following URL: http://wsw.com/webcast/dawson4/imv/.

Both webcasts will be archived for 90 days following the live presentation. A copy of the presentations will also be available on the Events, Webcasts & Presentations page of IMV’s website: www.imv-inc.com.

About IMV

IMV Inc., formerly Immunovaccine Inc., is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing DPX-Survivac as a combination therapy in multiple clinical studies with Incyte and Merck. Connect at www.imv-inc.com.

Contacts for IMV:
MEDIA 
Mike Beyer, Sam Brown Inc.
T: (312) 961-2502 E: mikebeyer@sambrown.com

INVESTOR RELATIONS
Pierre Labbé, Chief Financial Officer
T: (902) 492-1819 E: info@imv-inc.com   

Patti Bank, Managing Director, Westwicke Partners
O: (415) 513-1284
T: (415) 515-4572 E: patti.bank@westwicke.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.